Early versus deferred immunotherapy in urothelial carcinoma: a review of evidence and post-progression survival. Petrelli F, Ghidini A, Vavassori I, Rossitto M, et al. Int Urol Nephrol 2026;58:3969-3976.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Petrelli F, Ghidini A, Vavassori I, Rossitto M, et al. Early versus deferred immunotherapy in urothelial carcinoma: a review of evidence and post-progression survival. Int Urol Nephrol 2026;58:3969-3976.
PMID: 42012774